Nuvation Bio Inc. (NUVB) - Latest Market Data

Price & Market Data

Price: $4.70

Daily Change: -$0.09 / 1.91%

Daily Range: $4.63 - $4.89

Market Cap: $1,643,513,344

Daily Volume: 4,196,784

Performance Metrics

1 Week: 1.95%

1 Month: -10.65%

3 Months: -13.28%

6 Months: -32.28%

1 Year: 129.3%

YTD: -47.60%

About Nuvation Bio Inc. (NUVB)

Understand the dynamics of Nuvation Bio Inc. (NUVB). The stock is at 4.70, showing a -$0.09 / 1.91% change today. Market cap: 1,643,513,344. Performance over 1-week (1.95%) and 3-month (-13.28%) periods are highlighted.

Company Details

Employees: 298

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.

Selected stocks

Top KingWin Ltd (WAI)

Turn Therapeutics Inc. (TTRX)

Immutep Limited (IMMP)

Data I/O Corporation (DAIO)